All coverage
Industry fights over global vaccine patents are just warming up
By Christopher Rowland
Angela Merkel rejects US move to waive patents on vaccines
By Guy Chazan, Hannah Kuchler & Jim Brunsden
TRIPS waiver: there's more to the story than vaccine patents
By Hyo Yoon Kang, Siva Thambisetty & Jocelyn Bosse
All you need to know about the battle over COVID jab IP rights
By Virginia Pietromarchi
Biden Backs Waiving International Patent Protections For COVID-19 Vaccines
By Ashish Valentine & Emma Bowman
Explained: Intellectual property waiver for Covid-19 vaccines
By Aanchal Magazine & Prabha Raghavan
Germany rejects U.S. proposal to waive patents on COVID-19 vaccines
By Madeline Chambers, Douglas Busvine & Andreas Rinke
Waiver of patent rights on Covid-19 vaccines, in near term, may be more symbolic than substantive
By Matthew Herper, Helen Branswell & Damian Garde
U.S. backs waiving patent protections for Covid vaccines, citing global health crisis
By Thomas Franck, Kevin Breuninger & Amanda Macias
Covid: The vaccine patent row explained
By Dharshini David
U.S. reverses stance, backs giving poorer countries access to COVID vaccine patents
By Jeff Mason, David Lawder & Andrea Shalal-Esa
Biden administration to waive vaccine patent protection - The Washington Post
By Dan Diamond, Tyler Pager & Jeff Stein